BRCA1 and ovarian cancer: In 2018, Evans et al. [44] reported a dominantly inherited 5′ UTR variant associated with epigenetic BRCA1 silencing due to promoter hypermethylation in two families affected with a high incidence of breast and ovarian cancer.